[Mass treatment of Schistomsoma haematobium bilharziasis in the member states of the Organization for Coordination of the Campaign against Endemic Diseases in Central Africa].
The authors analysed the results of the control of Schistosoma haematobium bilharziasis in two central African countries, the Congo and the Cameroun . These results demonstrated: --The feasibility of mass screening by filtering urine; --The acceptability and efficacy of new antibilharzian drugs, praziquantel and oltipraz . With the aim of improving the cost/effectiveness ratio of these campagnes and taking into account the health requirements which exist and/or are desired by the population, the authors propose four modifications of the strategy of mass control: --The integration of Schistosoma haematobium bilharziasis control with the other regional health priorities; --Screening target groups;
D000293:Adolescent; D000328:Adult; D000350:Africa, Central; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D012548:Schistosoma haematobium; D012552:Schistosomiasis / Q000517:prevention & control*
Réflexions sur le traitement de masse des bilharzioses à Schistosoma haematobium dans les états membres de l'Organisation de Coordination pour la lutte contre les Endémies en Afrique Centrale (OCEAC).